McGinn Penninger Investment Management Inc. Has $7.70 Million Position in UnitedHealth Group Incorporated $UNH

McGinn Penninger Investment Management Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 169.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 22,300 shares of the healthcare conglomerate’s stock after acquiring an additional 14,015 shares during the quarter. UnitedHealth Group comprises approximately 4.5% of McGinn Penninger Investment Management Inc.’s holdings, making the stock its 5th largest position. McGinn Penninger Investment Management Inc.’s holdings in UnitedHealth Group were worth $7,700,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Nicolet Bankshares Inc. lifted its holdings in UnitedHealth Group by 8.8% in the third quarter. Nicolet Bankshares Inc. now owns 2,559 shares of the healthcare conglomerate’s stock worth $884,000 after purchasing an additional 208 shares during the period. Newbridge Financial Services Group Inc. raised its position in shares of UnitedHealth Group by 21.3% during the 3rd quarter. Newbridge Financial Services Group Inc. now owns 7,762 shares of the healthcare conglomerate’s stock worth $2,680,000 after buying an additional 1,363 shares in the last quarter. Pinnbrook Capital Management LP bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $3,789,000. Private Management Group Inc. acquired a new position in shares of UnitedHealth Group during the third quarter valued at approximately $215,000. Finally, Regal Investment Advisors LLC lifted its position in UnitedHealth Group by 41.4% in the third quarter. Regal Investment Advisors LLC now owns 4,373 shares of the healthcare conglomerate’s stock worth $1,510,000 after purchasing an additional 1,281 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $282.02 on Friday. The firm has a 50-day moving average of $303.36 and a two-hundred day moving average of $324.93. The firm has a market capitalization of $255.99 billion, a PE ratio of 21.38, a P/E/G ratio of 1.27 and a beta of 0.41. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same quarter in the prior year, the firm earned $6.81 EPS. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Monday, March 9th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend is Monday, March 9th. UnitedHealth Group’s payout ratio is presently 67.02%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Mizuho dropped their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a research note on Thursday, February 5th. Truist Financial lowered their target price on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Barclays dropped their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a report on Friday, January 30th. Finally, Morgan Stanley reduced their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a report on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Sen. Markwayne Mullin disclosed a purchase of $50k–$100k in UNH shares, a small institutional/insider-like buy that can be read as a signal of confidence and may attract retail/institutional attention. Trump Ally, New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades: Here’s What He Bought And Sold
• Positive Sentiment: Short-term price resilience: coverage noted UNH advancing while broader markets declined recently, a sign of relative strength that can draw momentum buyers. UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
• Neutral Sentiment: High investor attention: Zacks and Yahoo pieces highlight UNH as a heavily searched/watched stock; increased attention can boost liquidity and volatility but is not a directional catalyst by itself. UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
• Neutral Sentiment: Investor materials: a Barclays healthcare conference transcript was published; investors will parse management commentary for membership trends, margin drivers, and capital allocation but no surprise datapoint was flagged in headlines. UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
• Neutral Sentiment: Analyst coverage and model updates continue to circulate (stock-forecast pieces), which keep expectations and target-price dispersion visible to the market but provide mixed near-term directional pressure. UnitedHealth Group Incorporated (UNH) Stock Forecasts
• Negative Sentiment: Valuation/sector pressure concerns: commentary noting a ~39% 12‑month share decline and questioning whether current price reflects value could pressure sentiment and keep selling pressure if investors worry about sector headwinds or earnings risk. Is UnitedHealth Group (UNH) Pricing Reflect Sector Pressures After A 39% Share Price Decline

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.